文献库搜索 | GeneLibs

Meynard(G),Pereira(V),Paget-Bailly(S),Klaj... Cancers (Basel) 2026-03-06

...BRCA2 mutation analysis was proposed to all patients with mBC treated in seven French centers between 19 February and 30...

Xu(B),Chen(J),Peng(H),Su(X),He(C) J Pathol 2026-06-00

...BRCA2 p.S2670L (c.8009C>T) likely pathogenic mutation. LST demonstrated the strongest correlation with the integrated GI...

Zennami(K),Takimoto(T),Nukaya(T),Sumitomo(... Cancer Sci 2026-05-00

...BRCA2 alteration, and particularly BRCA2-SETD2 co-alteration, were associated with unfavorable outcomes, although the la...

Uesugi(K),Yamada(R),Nakamura(Y),Shimada(Y)... Intern Med 2026-03-17

...BRCA2 mutation received FOLFOX chemotherapy. Despite a favorable response from the primary tumor and a decline in the CA...

Xiao(D),Yao(J),Yang(X),Xie(Y),Zhou(X),Li(D... Cell Death Dis 2026-03-18

...BRCA2 and Rad51, and HR activation by competitively inhibiting the binding of BRCA2 and Rad51 to E3 ubiquitin ligase c-C...

El Hejjioui(B),Bouramtane(A),Bouguenouch(L... BMC Med Genomics 2026-03-19

...BRCA2 genes. By expanding the panel of genes, we hope to identify other genetic variants that may influence the diagnosi...

Yamazawa(K),Ueki(A),Kuga(A),Hinoi(T),Niits... J Med Genet 2026-05-25

The BRCA2 c.7847C>T (p.Ser2616Phe) variant is specific to the Japanese population and has long remained a variant of unc...

Zhang(YH),Teng(GS),Hu(X),Du(CX),Wang(Y),Zh... Zhonghua Yi Xue Za Zhi 2026-03-24

...BRCA2 and FANCD2 mutations (both are 2/6), ET patients had the highest proportion of BRCA2 mutations (3/10), and PMF pat...

Negri(S),Fornari(C),Ye(L),Inzoli(A),Costa(... Eur J Health Econ 2026-03-21

...BRCA2 PV carriers. Sensitivity analyses confirmed SS as the dominant strategy across all scenarios, with a > 80% probabi...

Falbo(L),Costanzo(V) Mol Cell 2026-04-02

...BRCA2-mediated stabilization, PCNA modifications, PARP1- and CTC1-STN1-TEN1 (CST)-dependent fill-in pathways, and the ba...